Transcription and RNA Regulation in Inflammation and Immunity
Organizer(s): Silvia Monticelli, K. Mark Ansel, Sarah Teichmann and Gioacchino NatoliDate: February 02 - 05, 2019
Location: Granlibakken Tahoe, Tahoe City, CA, USA
The immune system is a heavily armed but carefully tuned defense mechanism that must mount protective responses against invading pathogens, while at the same time avoiding excessive inflammation and inappropriate responses that can lead to severe tissue damage and disease. Properly regulated immune responses are the result of a complex interplay between chromatin modifications, transcription factors and post-transcriptional regulators that operate collectively within each cell to regulate the gene expression programs that control immune cell differentiation, maintenance of cell identity, and the orchestration of functional responses in a dynamic environment. Recent technical advances in genomics and single-cell analyses have brought new ideas and perspectives to investigation of the regulation of gene expression, and our understanding of the mechanisms and regulatory networks that operate in the immune system is advancing at an unprecedented rate. This meeting will be important to define the most impactful questions and future challenges in the field of transcriptional and post-transcriptional control of immune cells, and it will bring together rapidly expanding and evolving communities. The exchange of scientific knowledge and technical capabilities will foster opportunities for collaborations and interdisciplinary interactions among groups of scientists working on disparate aspects of regulation of gene expression in inflammation and immunity, highlighting the latest innovations and discoveries while shaping future directions for the field.
Scholarship Deadline: October 18 2018
Discounted Abstract Deadline: October 18 2018
Abstract Deadline: October 30 2018
Discounted Registration Deadline: November 29 2018
We gratefully acknowledge additional support from these exhibitors at this conference:
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1 R13 AI140575-01
Funding for this conference was made possible (in part) by 1 R13 AI140575-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.